In Treatment of Severe bacterial infections Kefage 250mg Injection works by killing bacteria which can cause serious infections. It is used to treat many different types of bacterial infections such as infections of the lungs (pneumonia) and urinary tract. It is given by a doctor or nurse into a vein and should not be self-administered. Kefage 250mg Injection usually makes you feel better very quickly but you should continue taking it as prescribed even when you feel better to make sure that all bacteria are killed and do not become resistant.
Consuming alcohol with Kefage 250mg Injection does not cause any harmful side effects.
Kefage 250mg Injection is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Kefage 250mg Injection is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby. Avoid prolonged use of Kefage 250mg Injection, since it may have possible effects such as rash and diarrhea.
It is not known whether Kefage 250mg Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Kefage 250mg Injection should be used with caution in patients with kidney disease. Dose adjustment of Kefage 250mg Injection may be needed. Please consult your doctor.
Kefage 250mg Injection is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Kefage 250mg Injection may not be needed in these patients. Please consult your doctor.
If you miss a dose of Kefage 250mg Injection, consult your doctor.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Shiron Pharmaceuticals || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Pride Healthcare || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Anevay Pharmaceuticals Pvt. Ltd. || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Mapra Laboratories Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Nootan Pharmaceuticals || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Fortune Life Sciences Private Limited || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Mediquest Inc. || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Cachet Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Elkos Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Coral Pharmaceuticals P Ltd || ₹14.5/tablet (25% cheaper)